Article
Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive…
medRxiv · 2022 · Anna R. Mäkelä
Key facts
| Title | Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariants |
|---|---|
| First author | Anna R. Mäkelä |
| Journal | medRxiv |
| Published | Dec 29, 2022 |
| DOI | 10.1101/2021.12.28.474326 |
| Devices mentioned | BK110039, K042152, K103302, K800781, K940422, K981784, K982100 |
| Product codes mentioned | CFN, DFZ, KIS, NDS, PCA, KIT, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1